Zimmer Biomet Holdings, Inc. Common Stock (ZBH)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — Aug 16, 2026Investment Snapshot
- Trading 26% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 6.5% — below-average profitability
- Revenue growing at 7% annually
Zimmer Biomet Holdings, Inc. Common Stock (ZBH) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NYSE , with a market capitalisation of $19.2 billion . Key value metrics: P/E ratio 23.4, P/B ratio 1.52, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Zimmer Biomet Holdings, Inc. Common Stock — Fundamental Analysis Summary
Zimmer Biomet Holdings, Inc. Common Stock (ZBH) is currently trading 26% above its Graham Number of $80.02, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 23.4x.
On financial health, ZBH shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 6.5% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.50.
StockPik's composite Value Score for ZBH is 74/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ZBH reports a high gross margin of 71.7% (sector average: 37.4%) and a solid operating margin of 16.2%.
ZBH shows revenue growing at 7% year-over-year, with earnings declining at 22%.
ZBH pays a modest dividend yield of 1.0%.